AMENDMENT
TO
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
(MARK ONE)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended January 31, 1997
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
----------------- -----------------
Commission file number 0-5958
------
MERIDIAN MEDICAL TECHNOLOGIES, INC.
-----------------------------------
(Exact name of Registrant as specified in its charter)
DELAWARE 52-0898764
------------------------------- ----------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
10240 OLD COLUMBIA ROAD, COLUMBIA, MARYLAND 21046
- ------------------------------------------- -------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 410-309-6830
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days.
YES [X] NO [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
CLASS OUTSTANDING AT FEBRUARY 28, 1997
---------------------------------------------
COMMON STOCK, $.10 PAR VALUE 2,912,502 SHARES
1
<PAGE>
THE PURPOSE OF THIS FILING IS TO AMEND THE 2nd QUARTER 10-Q FILED 3/97
BY ATTACHING THE FINANCIAL DATA SCHEDULE EXHIBIT 27
MERIDIAN MEDICAL TECHNOLOGIES, INC.
AMENDMENT
TO
FORM 10-Q
FOR THE QUARTER ENDED JANUARY 31, 1997
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits:
27 Financial Data Schedule
The following document is filed as part of this report:
1) Financial Data Schedule as Exhibit 27
contains summary financial information
extracted from the Consolidated Condensed
Balance Sheets and Statements of Income and
is qualified in its entirety by reference to
such financial statements.
2
<PAGE>
MERIDIAN MEDICAL TECHNOLOGIES, INC.
AMENDMENT
TO
FORM 10-Q
FOR THE QUARTER ENDED JANUARY 31, 1997
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MERIDIAN MEDICAL TECHNOLOGIES, INC.
- -----------------------------------
Registrant
May 27, 1997 By: /s/JAMES H. MILLER
- -------------------- --------------------------
Date James H. Miller
President and
Chief Executive Officer
(Principal Executive Officer)
May 27, 1997 By: /s/George Troy Braswell
- --------------------- ---------------------------
Date George Troy Braswell
Vice President
and Chief Financial Officer
(Principal Financial and
Accounting Officer)
3
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
Consolidated Condensed Balance Sheets and Statement of Income
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> JUL-31-1997
<PERIOD-START> NOV-01-1996
<PERIOD-END> JAN-31-1997
<EXCHANGE-RATE> 1.000
<CASH> 614,100
<SECURITIES> 260,900
<RECEIVABLES> 7,233,200
<ALLOWANCES> 0
<INVENTORY> 5,900,000
<CURRENT-ASSETS> 15,890,600
<PP&E> 27,801,000
<DEPRECIATION> 12,808,000
<TOTAL-ASSETS> 43,935,000
<CURRENT-LIABILITIES> 15,019,800
<BONDS> 13,504,100
0
0
<COMMON> 291,300
<OTHER-SE> 11,683,500
<TOTAL-LIABILITY-AND-EQUITY> 43,935,000<F1>
<SALES> 18,983,600
<TOTAL-REVENUES> 18,983,600
<CGS> 11,968,300
<TOTAL-COSTS> 21,894,800<F2>
<OTHER-EXPENSES> (124,300)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,606,400<F3>
<INCOME-PRETAX> (4,393,300)
<INCOME-TAX> 367,000
<INCOME-CONTINUING> (265,200)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5,025,500)
<EPS-PRIMARY> (4.94)
<EPS-DILUTED> (4.94)
<FN>
<F1>(29)Includes 3,948,600 of write off costs associated with merger
<F2>(25)Includes long-term notes payable of $13,504,100 of assumed debt related
to merger
<F3>(32)Includes $1,485,600 of interest expense on debt assumed in merger
</FN>
</TABLE>
